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Abstract Sodium channelopathies (NaCh), as part of the
non-dystrophic myotonic syndromes (NDMs), reflect a
heterogeneous group of clinical phenotypes accompanied
by a generalized myotonia. Because of recent availability of
diagnostic genetic testing in NDM, there is a need for
identification of clear clinical genotype–phenotype correla-
tions. This will enable clinicians to distinguish NDMs from
myotonic dystrophy, thus allowing them to inform patients
promptly about the disease, perform genetic counseling,
and orient therapy (Vicart et al. Neurol Sci 26:194–202,
2005). We describe the first distinctive clinical genotype–
phenotype correlation within NaCh: a strictly isolated
eyelid closure myotonia associated with the L250P muta-
tion in SCN4A. Using clinical assessment and needle EMG,
we identified this genotype–phenotype correlation in six
L250P patients from one NaCh family and confirmed this
finding in another, unrelated NaCh family with three L250P
patients.
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Introduction
Sodium channelopathies (NaCh), as part of the non-
dystrophic myotonic syndromes (NDMs), give rise to a
spectrumofclinicalheterogeneous phenotypescorresponding
with numerous causative mutations. About 50 different
sodium channel mutations have so far been identified in the
SCN4A gene encoding the skeletal muscle sodium channel.
In contrast to myotonic dystrophy (MD) that is characterized
by progressive muscle wasting and systemic manifestations,
complaints in NDMs are particularly caused by myotonia [2].
The clinical phenotypes of sodium (NaCh) and chloride
(ClCh) channelopathies have recently been redefined: a
higher frequency and severity of myotonia in the eyelid
muscles in NaCh, together with the presence of transient
paresis (in ClCh only) and paradoxical myotonia (in NaCh
o n l y )h a v eb e e nr e p o r t e d[ 3]. However, clinical differentia-
tion between NaCh and ClCh remains complicated because
these symptoms are always accompanied by a certain
degree of generalized myotonia. Moreover, identification of
genotype–phenotype correlations at the level of individual
mutations is limited.
Case report
The index patient, a 60-year-old woman (see Fig. 1a:
patient II-2, family 1), was referred to our clinic with
complaints primarily consisting of cramp-like sensations in
the muscles of the eyelids, for she could not open her eyes
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DOI 10.1007/s10048-009-0225-xnormally after strong eyelid closure, especially after crying,
sneezing, and after exposure to cold, for example cold
wind. These symptoms had first developed in early
childhood and did not improve as she grew older. She had
never experienced episodes of weakness.
Standardized neuromuscular examination revealed the
presence of action myotonia in the eyelid closure muscles:
after forceful contraction of the m. orbicularis oculi had
been maintained for several seconds the patient was unable
to open her eyelids and compensatory frontal muscle
contraction was needed to open the eyes. This delay passed
off gradually after warming up with repetitive contractions.
Clinical signs indicating myotonic involvement of the m.
levator palpebrae and the superior tarsel muscle (the eyelid
opening muscles) were not present: (1) lid lag sign, a
limitation of upper eyelid descent on downgaze, (2)
retraction sign, upper eyelid retraction above the corneoscl-
eral limbus while looking straight ahead. Ocular move-
ments were normal and no facial weakness was found. No
clinical signs of nonocular myotonia, such as grip action
mytonia in the hand flexor muscles and percussion
myotonia of the thenar and extensor forearm muscles, were
observed. There was no muscle weakness or wasting.
General investigations including serum sodium, potassium,
and creatine kinase were normal.
Needle electromyography (EMG) showed intense myo-
tonic discharges in the m. orbicularis oculi (Fig. 1b), in
sharp contrast to the other muscles investigated (left m.
biceps brachii, right m. interosseus dorsalis, right m. rectus
femoris, and the left m. tibialis anterior), which showed
minimal or no myotonic discharges. Mutation screening for
myotonic dystrophy types 1 and 2 were negative. Screening
of the sodium channel SCN4A gene identified the L250P
sodium channel mutation (Fig. 1c).
Methods and results
Five relatives of the index patient who reported no
complaints of generalized or eyelid myotonia and five
Fig. 1 a Pedigrees of the two Dutch families carrying the L250P
mutation and segregation of the mutation within the pedigrees. Family
1 is the family of the index patient described in this report. In Family 2
the L250P mutation was previously reported as a causative mutation
for sodium channel myotonia (SCM) associated with a warm-up
phenomenon. However, no further detailed phenotypic characteristics
were reported in these patients [2]. Pedigree symbols: circles female,
squares male, slashed square deceased, closed symbols affected
individuals, arrow the index patient, section sign refused participation
in this study, asterisk see supplemental data: Videos 1 and 2 showing
action myotonia in this patient. b Needle EMG segment shows an
isolated myotonic train with changes in frequency and amplitude;
recorded from the m. orbicularis oculi in the index patient (II-2, family
1) after myotonic activity was triggered by needle movement. The
myotonic train is preceded and followed by motor unit activity of the
m. orbicularis oculi. c Results of mutational analysis. The upper
sequence within the electropherogram represents the sequence of the
index patient (II-2, family 1) encompassing the c.749T>C mutation
(p.L250P). The mutation is indicated with an arrow. The lower
sequence represents the control sequence. The L250P mutation was
confirmed by direct nucleotide sequence analysis of the SCN4A gene
in the affected individuals that are marked as carriers of the L250P
mutation in Fig. 1a
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but no generalized myotonic symptoms (Fig. 1a: family 1)
were examined through clinical assessment, needle EMG,
and genetic screening. Blood samples had been collected
after obtaining written informed consent and ethic approval
was provided by the medical ethics committee of the
Radboud University Nijmegen Medical Centre. Direct
nucleotide sequence analysis confirmed the presence of the
L250P mutation only in the five affected relatives. The
asymptomatic relatives had no mutation at this site. Addition-
ally, three L250P patients from a previously reported L250P
family (Fig. 1a: Family 2) were clinically reevaluated and
examined with needle EMG [4]. In all nine L250P patients,
eyelid closure myotonia was aggravated by exercise and cold
temperatures and the clinical assessment revealed the
presence of action myotonia in the m. orbicularis oculi in
all nine (see supplemental data: Video 1), in the absence of
action myotonia in the hand flexor muscles (Video 2)e x c e p t
for one patient (Fig. 1a: patient III-5 family 1). The needle
EMG demonstrated continuous myotonic discharges in the m.
orbicularis oculi with minimal or no myotonic discharges in
the other muscles examined (left m. biceps brachii, right m.
interosseus dorsalis, right m. rectus femoris, and the left m.
tibialis anterior) (Table 1).
Discussion
Until now, only two specific SCN4A mutations in NaCh have
been related to a distinctive clinical genotype–phenotype: (1)
the M1476I mutation associated with severe painful myoto-
nia and a clear warm-up phenomenon and (2) the N1297K
mutation associated with a severe neonatal form of NaCh
with severe desaturation, early-onset muscle hypertrophy,
psychomotor retardation, and fatal outcome [5, 6].
In contrast to these two clinical phenotypes that are
typically characterized by generalized myotonia and dis-
tinctive additional features, we report on the first distinctive
clinical genotype–phenotype correlation within the sodium
channelopathies that we found to be associated with an
isolated eyelid closure myotonia due to the L250P
mutation. Being at the mild end of the NaCh spectrum,
this phenotype is characterized by intense myotonia of the
m. orbicularis oculi with a warm-up phenomenon and
minimal or no myotonia elsewhere.
The pathogenic status of this mutation is clear: the
L250PmutationintheSCN4A gene results in a substitution
of the highly conserved leucine residue into a proline
residue in the α-subunit of the skeletal muscle voltage-
gated sodium channel (Nav1.4). In vitro electrophysiolog-
ical studies using patch-clamp analysis showed that
mutations occurring in the voltage sensor domains of the
channel cause myotonia through a disruption of fast
inactivation.
In vivo, this results in hyperexcitability of the muscle
sarcolemmalmembrane,causing the subsequentmyotonia [1].
However, the question remains why in patients with the
L250P mutation myotonia is almost exclusively restricted to
the m. orbicularis oculi. Notwithstanding recent studies
showing more neuromuscular junctions with clustering of
Table 1 Phenotypic features of two Dutch families carrying the L250P mutation
General Triggering factors of myotonia Action myotonia Myotonia
No Sex Age (years) SCM onset C E ES CM S P Eyelid muscles Hand flexor
muscles
Myotonic
discharges
Family 1
II-2 F 60 Childhood + −− − −+ Present Absent m. orbicularis oculi
II-6 M 56 Childhood + + + −− − Present Absent m. orbicularis oculi
III-3 F 34 Neonatal + + + + + + Present Absent m. orbicularis oculi
III-5 M 23 Childhood + + −− − − Present Present
a m. orbicularis oculi
III-9 F 23 Neonatal + −− − −−Present Absent m. orbicularis oculi
III-10 M 19 Neonatal + + −− − − Present Absent m. orbicularis oculi
Family 2
I-1 M 73 Childhood + + −− + − Present Absent m. orbicularis oculi
II-2 M 48 Childhood + + −− − − Present Absent m. orbicularis oculi
II-5 F 41 Childhood + + −− + + Present Absent m. orbicularis oculi
F female, M male, C cold, E exercise, ES (emotional) stress, CM carbohydrate-rich meal, S sleep deprivation, P pregnancy
aIn patient III-5 (family 1) minor action myotonia was clinically observed in the hand flexor muscles without the presence of actual symptoms
related to hand or other nonocular myotonia
Neurogenetics (2010) 11:257–260 259the voltage-gated sodium channels at the sarcolemmal
membrane in human facial muscles, additional modifying
genes must play a large role in this resultant phenotype [7, 8].
In view of our case report, clinicians should be aware
that patients with sodium channelopathies may present with
an isolated eyelid closure myotonia. In these NaCh cases
we recommend SCN4A screening with particular attention
for the L250P mutation. Besides, testing for eyelid closure
myotonia is a very important clinical test to distinguish
between MD and NDMs because, unlike NDMs, MD is
characterized by a severe degree of weakness of the eyelid
opening muscles and not by eyelid closure myotonia [9].
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